PMID- 32738101
OWN - NLM
STAT- MEDLINE
DCOM- 20210514
LR  - 20210514
IS  - 1473-2165 (Electronic)
IS  - 1473-2130 (Linking)
VI  - 19
IP  - 9
DP  - 2020 Sep
TI  - Physician survey on pre-/postprocedure measures for injectable treatments.
PG  - 2246-2251
LID - 10.1111/jocd.13625 [doi]
AB  - INTRODUCTION: Every year in the United States, over 1 billion dollars are spent 
      on aesthetic injectables, such as soft tissue fillers and neurotoxins. In 2018, 
      the total amount of injectable treatments performed surpassed 2 671 130 
      procedures. While often mild and transient, adverse events (AEs) can occur 
      following these procedures. AEs may include common side effects such as bruising, 
      or rare, but serious AEs such as infections. While previous investigators have 
      evaluated methods of reducing risks of AEs due to the treatment procedure itself, 
      few investigations have evaluated measures employed before and/or after treatment 
      (ie, peri-procedure). METHODS: An electronic survey was sent to aesthetic 
      clinicians with experience performing injectable treatments. The survey collected 
      information regarding general information (eg, demographics and specialty), type 
      of injectable devices used, current peri-procedures, and an exploration of future 
      options for peri-procedural measures. RESULTS: Most aesthetic clinicians did not 
      use prophylactic topical or systemic antimicrobials, nor prophylactic topical 
      antiviral therapy. However, approximately 65% of clinicians reported using 
      prophylactic systemic antivirals for patients with a history of herpes simplex 
      virus. A variety of products were used to prepare the skin prior to injectable 
      procedures. Postprocedure, multiple over-the-counter wound repair products were 
      recommended by >70% of injectors. However, there was a large variety of products 
      recommended with no majority consensus. CONCLUSIONS: Currently, there are no 
      peri-procedural standards of practice when performing aesthetic injectable 
      treatments. Efforts are underway for the development of best-practice algorithms.
CI  - (c) 2020 Wiley Periodicals LLC.
FAU - Gold, Michael H
AU  - Gold MH
AUID- ORCID: 0000-0002-5183-5433
AD  - Gold Skin Care Center and Tennessee Clinical Research Center, Nashville, TN, USA.
AD  - University School of Medicine and Nursing, Nashville, TN, USA.
FAU - Andriessen, Anneke
AU  - Andriessen A
AUID- ORCID: 0000-0001-5930-4162
AD  - Radboud UMC Nijmegen, Andriessen Consultants, Malden, The Netherlands.
FAU - Hu, Shasa
AU  - Hu S
AUID- ORCID: 0000-0003-3479-733X
AD  - Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of 
      Miami Miller School of Medicine, Miami, FL, USA.
AD  - Department of Dermatology and Cutaneous Surgery, Sylvester Comprehensive Cancer 
      Center, Miami, FL, USA.
FAU - Vega, Janelle H
AU  - Vega JH
AUID- ORCID: 0000-0001-6552-5666
AD  - Mayoral Dermatology, Miami, FL, USA.
FAU - Goldberg, David J
AU  - Goldberg DJ
AUID- ORCID: 0000-0002-8950-439X
AD  - Skin Laser & Surgery Specialists of NY and NJ, Hackensack, NJ, USA.
AD  - Icahn School of Medicine at Mount Sinai, New York, NY, USA.
FAU - Grover, Komel V
AU  - Grover KV
AUID- ORCID: 0000-0002-3458-3027
AD  - Strategic Development, Swiss American CDMO, Dallas, TX, USA.
FAU - Lorenc, Z Paul
AU  - Lorenc ZP
AUID- ORCID: 0000-0002-5119-8825
AD  - Lorenc Aesthetic Plastic Surgery Center, New York, NY, USA.
AD  - Department of Plastic Surgery, Lenox Hill Hospital, New York, NY, USA.
FAU - Mandy, Stephen H
AU  - Mandy SH
AUID- ORCID: 0000-0003-4539-2725
AD  - Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of 
      Miami Miller School of Medicine, Miami, FL, USA.
LA  - eng
GR  - Swiss American, LLC./
PT  - Journal Article
DEP - 20200801
PL  - England
TA  - J Cosmet Dermatol
JT  - Journal of cosmetic dermatology
JID - 101130964
SB  - IM
MH  - *Cosmetic Techniques/adverse effects
MH  - Esthetics
MH  - Humans
MH  - Injections/adverse effects
MH  - *Physicians
MH  - Rejuvenation
OTO - NOTNLM
OT  - aesthetic injectables
OT  - injectables
OT  - peri-procedural standards
OT  - pre-postprocedure measures
OT  - survey
EDAT- 2020/08/02 06:00
MHDA- 2021/05/15 06:00
CRDT- 2020/08/02 06:00
PHST- 2020/05/24 00:00 [received]
PHST- 2020/07/07 00:00 [accepted]
PHST- 2020/08/02 06:00 [pubmed]
PHST- 2021/05/15 06:00 [medline]
PHST- 2020/08/02 06:00 [entrez]
AID - 10.1111/jocd.13625 [doi]
PST - ppublish
SO  - J Cosmet Dermatol. 2020 Sep;19(9):2246-2251. doi: 10.1111/jocd.13625. Epub 2020 
      Aug 1.